The publication includes a subset of data from the ACTION PMR stroke study and provides early evidence that the Swoop® system is a promising tool for enabling critical stroke treatment choices in ...

A nanomaterial based on a platform developed by Professor Samuel Stupp crosses the blood-brain barrier and targets harmful ...

A new analysis supports the use of intravenous (IV) tenecteplase over IV alteplase (tissue plasminogen activator) for treatment of acute ischemic stroke. The analysis found that patients with ischemic ...

Acute stroke imaging is a rapidly evolving field. Preliminary evidence exists to suggest that a tissue clock to guide acute stroke treatment is possible with advanced CT and MRI techniques. Within the ...

Every year, millions of lives are suddenly, swiftly transformed by a stroke, which occurs when a blood vessel traveling towards the brain becomes obstructed, causing neurons to die off. Strokes are ...

“Our results suggest that forensic applications of DNAm clocks using non-blood tissue types will provide age estimates that are not as accurate as predictions based on blood, especially if using ...

If a stroke is the result of a blocked artery to the brain, the clot busting drug tissue plasminogen activator (tPA) must be delivered within three hours of the first symptoms to improve chances of ...